Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H3170

Blue Cross and Blue Shield of Nebraska

6,774 members

3.5

Below the 4 star line

Ask about H3170

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

2 · 1.0 pt to 3★

Medication Adherence for Hypertension (RAS antagonists)

4 · 3.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

3 · 1.0 pt to 4★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.1
C28 Members Choosing to Leave the Plan410%
C17 Plan All-Cause Readmissions3x212%
C15 Reducing the Risk of Falling147%
C16 Improving Bladder Control447%
C06 Monitoring Physical Activity248%
C19 Transitions of Care249%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions263%
C11 Diabetes Care – Eye Exam267%
C13 Kidney Health Evaluation for Patients with Diabetes371%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.